raloxifene hydrochloride has been researched along with Esophageal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brookhart, MA; Patrick, A; Solomon, DH | 1 |
Ansar, A; Hussey, DJ; Sukocheva, OA; Watson, DI; Wee, C | 1 |
2 other study(ies) available for raloxifene hydrochloride and Esophageal Neoplasms
Article | Year |
---|---|
More on reports of esophageal cancer with oral bisphosphonate use.
Topics: Administration, Oral; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Esophageal Neoplasms; Humans; Incidence; Osteoporosis; Raloxifene Hydrochloride; SEER Program; United States | 2009 |
Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Barrett Esophagus; Cadherins; Cell Count; Cell Culture Techniques; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ki-67 Antigen; Male; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen | 2013 |